State Street Corp Regenxbio Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Regenxbio Inc. stock. As of the latest transaction made, State Street Corp holds 2,782,883 shares of RGNX stock, worth $21.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,782,883
Previous 2,873,235 3.14%
Holding current value
$21.2 Million
Previous $33.6 Million 13.16%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$10.49 - $14.39 $947,792 - $1.3 Million
-90,352 Reduced 3.14%
2,782,883 $29.2 Million
Q2 2024

Aug 14, 2024
SELL
$11.51 - $21.53 $2.87 Million - $5.37 Million
-249,404 Reduced 7.99%
2,873,235 $33.6 Million
Q1 2024

May 15, 2024
BUY
$12.17 - $24.61 $5.98 Million - $12.1 Million
491,419 Added 18.68%
3,122,639 $65.8 Million
Q4 2023

Feb 14, 2024
BUY
$12.89 - $20.82 $1.65 Million - $2.66 Million
127,739 Added 5.1%
2,631,220 $47.2 Million
Q3 2023

Nov 14, 2023
SELL
$16.46 - $19.99 $4.26 Million - $5.17 Million
-258,635 Reduced 9.36%
2,503,481 $41.2 Million
Q2 2023

Aug 14, 2023
BUY
$17.23 - $21.71 $3.12 Million - $3.93 Million
180,853 Added 7.01%
2,762,116 $55.2 Million
Q1 2023

May 15, 2023
SELL
$18.08 - $24.55 $2.44 Million - $3.31 Million
-134,926 Reduced 4.97%
2,581,263 $48.8 Million
Q4 2022

Feb 14, 2023
BUY
$20.4 - $24.73 $1.96 Million - $2.38 Million
96,085 Added 3.67%
2,716,189 $61.6 Million
Q3 2022

Nov 15, 2022
SELL
$22.29 - $35.04 $4.04 Million - $6.36 Million
-181,390 Reduced 6.47%
2,620,104 $69.2 Million
Q2 2022

Aug 15, 2022
BUY
$19.35 - $35.04 $2.86 Million - $5.18 Million
147,728 Added 5.57%
2,801,494 $69.2 Million
Q1 2022

May 16, 2022
BUY
$24.62 - $34.31 $4.03 Million - $5.61 Million
163,513 Added 6.57%
2,653,766 $88.1 Million
Q4 2021

Feb 14, 2022
BUY
$30.19 - $40.28 $1.9 Million - $2.53 Million
62,815 Added 2.59%
2,490,253 $81.4 Million
Q3 2021

Nov 15, 2021
BUY
$29.09 - $45.68 $4.76 Million - $7.47 Million
163,557 Added 7.22%
2,427,438 $102 Million
Q2 2021

Aug 16, 2021
SELL
$32.46 - $40.48 $1.04 Million - $1.29 Million
-31,906 Reduced 1.39%
2,263,881 $88 Million
Q1 2021

May 17, 2021
BUY
$33.61 - $49.95 $15.9 Million - $23.7 Million
474,131 Added 26.03%
2,295,787 $78.3 Million
Q4 2020

Feb 16, 2021
SELL
$26.52 - $49.35 $8.55 Million - $15.9 Million
-322,241 Reduced 15.03%
1,821,656 $82.6 Million
Q3 2020

Nov 10, 2020
SELL
$27.01 - $40.26 $2.75 Million - $4.1 Million
-101,743 Reduced 4.53%
2,143,897 $59 Million
Q2 2020

Aug 14, 2020
BUY
$27.75 - $43.44 $7.74 Million - $12.1 Million
279,077 Added 14.19%
2,245,640 $82.7 Million
Q1 2020

May 11, 2020
BUY
$21.5 - $54.2 $42.3 Million - $107 Million
1,966,563 New
1,966,563 $63.7 Million

Others Institutions Holding RGNX

# of Institutions
196
Shares Held
43M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email